Below is a collection of strong APL Bioengineering articles that were highly cited in 2022 | | Below is a collection of exciting APL Bioengineering articles that were highly cited in 2022. | These papers showcase the very best of the journal. Take a look at what has interested your colleagues and inspired their research. And, listen to a message from Editor-in-Chief Justin Cooper-White. | | Our authors saw over 2,100 downloads on average of their articles last year. | | | | | | | Viscous shaping of the compliant cell nucleus Richard B. Dickinson, Aditya Katiyar, Christina R. Dubell, Tanmay P. Lele READ MORE > | | | Engineering CAR T cells for enhanced efficacy and safety Yiqian Wu, Ziliang Huang, Reed Harrison, Longwei Liu, et al. READ MORE > | | | On the nuclear pore complex and its emerging role in cellular mechanotransduction Atsushi Matsuda, Mohammad R. K. Mofrad READ MORE > | | | Nuclear lamins: Structure and function in mechanobiology Amir Vahabikashi, Stephen A. Adam, Ohad Medalia, Robert D. Goldman READ MORE > | | | The accumulation of particles in ureteric stents is mediated by flow dynamics: Full-scale computational and experimental modeling of the occluded and unoccluded ureter Ali Mosayyebi, Aravinthan Vijayakumar, Maryam Mosayebi, Dirk Lange, et al. READ MORE > | | | Wearable devices for continuous monitoring of biosignals: Challenges and opportunities Tucker Stuart, Jessica Hanna, Philipp Gutruf READ MORE > | | | Microfluidic techniques for isolation, formation, and characterization of circulating tumor cells and clusters Celine Macaraniag, Qiyue Luan, Jian Zhou, Ian Papautsky READ MORE > | | | Share on your social channels | | | | | | | | Follow us on social media | |
| | | Copyright © 2023 AIP Publishing. All rights reserved. 1305 Walt Whitman Rd., Melville, NY 11747
You are receiving this email because you have opted-in to receive alerts from us. To guarantee delivery of this email please add journals@aip-info.org to your address book and safe senders list.
If you no longer wish to receive emails from us then please unsubscribe or amend your settings.
| | | | |
No comments:
Post a Comment